Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
H1 2017
|
VBLT |
|
Phase 3 Results |
Oncology |
Fast Track, Orphan Drug |
|
Q2 2017
|
VSAR |
|
Phase 3 Results |
Endocrine |
Orphan Drug |
|
H1 2017
|
XENE |
|
Phase 2b Results |
Neurology |
None |
|
H1 2017
|
XNCR |
|
Phase 2 Results |
Other |
None |
|
H1 2017
|
XNCR |
|
Phase 1 Results |
Respiratory |
None |
|
Q3 2017
|
PBYI |
|
PDUFA |
Oncology |
None |
|
Q3 2016
|
WINT |
|
Phase 2a Results |
Respiratory |
Fast Track |
|
Q3 2016
|
ALDA |
|
Phase 2b Results |
Neurology |
None |
|
H2 2017
|
RETA |
|
Phase 2 Results |
Respiratory |
Orphan Drug |
|
H2 2017
|
RETA |
|
Phase 1/2 Results |
Oncology |
None |
|